Healthcare Sector

BMY

Market Tracker

$61.14
-0.46
(-0.75%)
1:16 am
Next Earnings: (est.) 07/27/23 12:00 am
  • BMY (Selected)

    Bristol-Myers Squibb Company

BMY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

BMY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BMY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BMY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

BMY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BMY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
03/20/2026 CALL $62.00 4,000 +4,000
03/20/2026 PUT $62.00 4,000 +4,000
12/18/2026 PUT $55.00 4,429 +2,542 +134.71%
01/15/2027 PUT $60.00 5,070 +501 +10.97%
06/18/2026 CALL $62.50 5,299 +478 +9.91%
03/20/2026 CALL $62.50 18,778 +432 +2.35%
03/20/2026 CALL $60.00 26,772 -30 -0.11%
06/18/2026 PUT $47.00 255 -56 -18.01%
06/17/2027 CALL $65.00 186 -78 -29.55%
06/18/2026 CALL $52.50 2,118 -94 -4.25%
12/18/2026 CALL $67.50 1,204 -103 -7.88%
01/15/2027 CALL $65.00 3,076 -135 -4.20%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BMY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.07% 64.63M 4.03B
Vanguard 500 Index Fund 2.34% 49.15M 3.06B
Fidelity 500 Index Fund 1.11% 23.31M 1.45B
SPDR S&P 500 ETF Trust 1.09% 23.02M 1.43B
iShares Core S&P 500 ETF 0.90% 18.98M 1.18B
Vanguard Index-Value Index Fund 0.87% 18.37M 1.14B
JP Morgan Equity Income Fund 0.82% 17.35M 1.08B
Select Sector SPDR Fund-Health Care 0.82% 17.27M 1.08B
American Mutual Fund Inc 0.78% 16.49M 1.03B
Vanguard Institutional Index Fund-Institutional Index Fund 0.71% 14.9M 927.91M

BMY News

  • Advanced Drug Delivery Market to Grow 10.2% Annually Through 2030

    02/25 01:54 pm

    GlobeNewswire Inc.

    Read more
  • Kyverna Therapeutics Appoints Biotech Leaders Sravan Emany and Andrew Miller to Board of Directors

    02/24 09:00 am

    GlobeNewswire Inc.

    Read more
  • Bristol-Myers Touts Promising Data From Blood Disorder Study

    02/23 02:43 pm

    Benzinga

    Read more
  • Starton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma

    02/19 09:00 am

    GlobeNewswire Inc.

    Read more
  • CTLA-4 Inhibitors Competitive Landscape Research Report 2026: Comprehensive Insights About 40+ Companies and 50+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type

    02/18 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Checkpoint Inhibitors Competitive Landscape Report 2026: Comprehensive Insights About 50+ Companies and 60+ Drugs

    02/18 11:49 am

    GlobeNewswire Inc.

    Read more
  • Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline Overview: Insights into 80+ Leading Companies and 100+ Novel Treatments | DelveInsight

    02/09 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Flags Data-Rich 2026 After Solid Quarter

    02/05 11:07 am

    Benzinga

    Read more
  • What's Going On With Bristol-Myers Squibb Stock Today?

    02/04 02:40 pm

    Benzinga

    Read more
  • CytomX Therapeutics to Present at Upcoming February Conferences

    02/04 09:00 am

    GlobeNewswire Inc.

    Read more
  • Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Astute Analytica

    02/03 02:56 am

    GlobeNewswire Inc.

    Read more
  • Autologous Cell Therapy Market Size to Reach US$ 44.55 Billion by 2033 | Astute Analytica

    01/27 02:43 pm

    GlobeNewswire Inc.

    Read more
  • 1 ETF Could Turn $500 Monthly Into a $800,000 Portfolio That Pays $24,000 in Annual Dividend Income

    01/24 08:30 pm

    The Motley Fool

    Read more
  • Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million

    01/22 03:02 pm

    Benzinga

    Read more
  • The Best Stocks to Invest $1,000 in Right Now

    01/21 12:45 pm

    The Motley Fool

    Read more
  • High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider

    01/21 12:00 pm

    GlobeNewswire Inc.

    Read more
  • Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative

    01/21 10:43 am

    Investing.com

    Read more
  • U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

    01/21 05:52 am

    GlobeNewswire Inc.

    Read more
  • Bristol Myers, Microsoft Aim To Catch Lung Cancer Early With New AI Tool

    01/20 02:02 pm

    Benzinga

    Read more
  • Systemic Lupus Erythematosus Market to Exhibit Growth at a CAGR of 9.4% During the Forecast Period (2025–2034) Owing to Rising Use of Biologics – Approvals of BENLYSTA and SAPHNELO, Plus a Strong Pipeline | DelveInsight

    01/13 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Amgen Buys Dark Blue In $840 Million Bet On New Leukemia Drugs

    01/07 02:45 pm

    Benzinga

    Read more
  • 2 Dividend ETFs to Buy With $500 and Hold Forever

    01/07 08:30 am

    The Motley Fool

    Read more
  • Scenic Biotech Enters License and Research Agreement with Ono Pharmaceutical

    01/07 06:00 am

    GlobeNewswire Inc.

    Read more
  • AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial

    01/06 07:43 am

    Benzinga

    Read more
  • 1 Top ETF I Plan to Load Up on in 2026

    01/02 09:05 am

    The Motley Fool

    Read more
  • Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold Forever

    12/30 10:15 am

    The Motley Fool

    Read more
  • 3 Drug Stocks to Buy at a Discount

    12/27 05:28 pm

    The Motley Fool

    Read more
  • Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever

    12/24 06:26 pm

    The Motley Fool

    Read more
  • Should Retirees Pull Their Money Out of the Stock Market in 2026?

    12/21 05:30 am

    The Motley Fool

    Read more
  • Immuno-oncology Clinical Trials Market Projected to Reach USD 23.63 Billion by 2032 at a CAGR of 12.37% - SNS Insider

    12/14 09:32 am

    GlobeNewswire Inc.

    Read more
  • Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.

    12/14 06:15 am

    The Motley Fool

    Read more
  • BioNTech-Bristol Drug Shows Hope For Breast Cancer Patients With Few Options

    12/09 01:38 pm

    Benzinga

    Read more
  • Antibody Discovery Market to Reach USD 17.68 Billion by 2032, Driven by Rising Demand for Targeted Therapies and Advancements in AI Powered Antibody Engineering – SNS Insider

    12/07 10:26 am

    GlobeNewswire Inc.

    Read more
  • Do These 3 Healthcare Stocks Need a Checkup?

    12/05 05:05 pm

    The Motley Fool

    Read more
  • Bristol Myers Pushes Data Readout For Key Alzheimer's Psychosis Study After Irregularities

    12/03 02:51 pm

    Benzinga

    Read more
  • 2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

    11/30 10:05 pm

    The Motley Fool

    Read more
  • 2 Top Dividend Stocks to Buy and Hold

    11/30 05:05 am

    The Motley Fool

    Read more
  • Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend?

    11/29 07:18 am

    The Motley Fool

    Read more
  • Geriatric Care Services Market is expected to generate a revenue of USD 2.03 Billion by 2032, Globally, at 7.98% CAGR: Verified Market Research®

    11/27 11:50 pm

    GlobeNewswire Inc.

    Read more
  • Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

    11/24 02:14 pm

    Benzinga

    Read more
  • Metabolic Collaboration and Licensing Agreements Analysis Report and Directory 2025: Upfront, Milestone, and Royalties for 576 Deals by Company A-Z, Therapy Focus and Technology Type

    11/19 11:58 am

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Faces Another Trial Disappointment As Heart Drug Milvexian Fails To Show Efficacy

    11/14 12:17 pm

    Benzinga

    Read more
  • The Market’s a Ripoff Right Now, but These 4 High Yielders Aren’t

    11/14 06:37 am

    Investing.com

    Read more
  • Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

    11/13 12:10 pm

    Benzinga

    Read more
  • CytomX Therapeutics to Present at the Jefferies London Healthcare Conference

    11/13 09:00 am

    GlobeNewswire Inc.

    Read more
  • Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

    11/07 08:00 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: